IL2 and cancer: The relative decrease in these populations may be due to changes in adaptive immune responses in cancer patients: for instance, regulatory T cells can deprive NK cells of IL-2 and decrease their activation and proliferation33, and there may be less M1 macrophages differentiation due to the lack of Th1 responses.